APA (7th ed.) Citation

Glund, S., Stangier, J., van Ryn, J., Schmohl, M., Moschetti, V., Haazen, W., . . . Kreuzer, J. (2017). Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study. Clinical pharmacokinetics, 56(1), 41-54. https://doi.org/10.1007/s40262-016-0417-0

Chicago Style (17th ed.) Citation

Glund, Stephan, et al. "Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study." Clinical Pharmacokinetics 56, no. 1 (2017): 41-54. https://doi.org/10.1007/s40262-016-0417-0.

MLA (9th ed.) Citation

Glund, Stephan, et al. "Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study." Clinical Pharmacokinetics, vol. 56, no. 1, 2017, pp. 41-54, https://doi.org/10.1007/s40262-016-0417-0.